Patents by Inventor Mario Scherer
Mario Scherer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240124925Abstract: A method for assessing the status of degradation and/or integrity of one or more nucleic acids in a sample, which includes amplifying at least two overlapping regions within at least one locus and detecting the amount of the amplification products using at least two probes, where one probe binds to an overlapping region and the other probe binds to a non-overlapping region. Also, a method of designing primers and/or probes for amplifying at least two overlapping regions within at least one single copy locus or multicopy locus. Also a primer and a primer pair for amplifying at least two overlapping regions from one nucleic acid template which is a multicopy locus present in loci in the human genome. Also a kit including primers and/or probes for assessing the status of degradation and/or integrity of one or more nucleic acids in a sample.Type: ApplicationFiled: September 15, 2023Publication date: April 18, 2024Inventors: Miroslav VRANES, Ralf PEIST, Mario SCHERER, Stefan Otto CORNELIUS
-
Publication number: 20240084363Abstract: Oligonucleotide primers and probes for quantifying and/or detecting human male DNA in a forensic sample. The oligonucleotides are useful for amplifying a multicopy locus within the human Y-chromosome (MCL-Y) that shares at least 80% sequence identity to a sequence according to SEQ ID NO. 3 over a stretch of at least 60 base pairs. The oligonucleotides hybridize under stringent conditions to a nucleic acid having at least one sequence selected from the group consisting of SEQ ID NO. 3 to SEQ ID NO. 11 and/or SEQ ID NO. 17 to SEQ ID NO. 25. Kits including the oligonucleotide primers, probes and/or primer pairs and reagents for performing an amplification reaction on DNA recovered from a forensic sample are also disclosed.Type: ApplicationFiled: October 6, 2023Publication date: March 14, 2024Inventors: Miroslav VRANES, Ralf PEIST, Mario SCHERER, Stefan Otto CORNELIUS, Margaretha KÖNIG
-
Patent number: 11767553Abstract: A kit for use in assessing the status of nucleic acid degradation and/or the integrity of one or more nucleic acids in a sample by amplifying at least two overlapping regions within at least one locus and detecting the amount of the at least two amplification products. The kit includes a primer and at least two probes that bind under stringent conditions to a sequence that shares at least 80% sequence identity to a sequence selected from the group of sequences consisting of SEQ ID NO. 6 to SEQ ID NO. 47 over a stretch of 80 base pairs, or to a reverse complement thereof. One of the at least two probes binds to one of the at least two overlapping regions and the other of the at least two probes binds to a non-overlapping region.Type: GrantFiled: October 13, 2021Date of Patent: September 26, 2023Assignee: Qiagen, GmbHInventors: Miroslav Vranes, Ralf Peist, Mario Scherer, Stefan Otto Cornelius
-
Publication number: 20220333176Abstract: An oligonucleotide suitable for use as a detection probe in a method for evaluating the amplification efficiency, the presence of inhibitors, degradation and/or for performing a quantification analysis of a target nucleic acid in a real-time amplification reaction. The oligonucleotide probe is preferably SEQ ID NO. 4, a reverse complement of SEQ ID NO. 4, an oligonucleotide that shares 95% sequence identity with SEQ ID NO. 4, or an oligonucleotide that shares 95% sequence identity with a reverse complement of SEQ ID NO. 4. Also a kit including an internal nucleic acid control template, a set of primers for amplifying the internal nucleic acid control template, and the oligonucleotide probe.Type: ApplicationFiled: May 19, 2022Publication date: October 20, 2022Inventors: Miroslav VRANES, Ralf PEIST, Mario SCHERER, Stefan Otto CORNELIUS
-
Patent number: 11345952Abstract: PCR that allows the researchers to amplify a desired DNA requiring only tiny amounts of sample. Such amplification reactions are technically challenging and are often hampered by several practical issues such as the presence of PCR inhibitors, sample degradation and low quantities of said sample. The invention addresses these issues with a method for evaluating the amplification efficiency and/or the presence of inhibitors and/or degradation and/or performing a quantification of a nucleic acid in a real-time amplification reaction comprising: optionally amplifying in a reaction composition a first target nucleic acid using a first primer pair in a real-time amplification reaction, (i) amplifying in said reaction composition one or more second internal nucleic acid control templates (IC) with a length of between 50 and 2000 nucleotides, wherein the second nucleic acid has a sequence selected from the group of: i) SEQ ID NO.Type: GrantFiled: September 15, 2017Date of Patent: May 31, 2022Assignee: Qiagen GmbHInventors: Miroslav Vranes, Ralf Peist, Mario Scherer, Stefan Otto Cornelius
-
Patent number: 11253797Abstract: The present invention relates to a chromatographic device for isolating and purifying nucleic acids, preferably genomic DNA, by gel filtration chromatography, a method for isolating and purifying nucleic acids, preferably genomic DNA, using this device and a kit comprising this device.Type: GrantFiled: July 7, 2016Date of Patent: February 22, 2022Assignee: QIAGEN GmbHInventors: Roland Fabis, Markus Müller, Jörg Hucklenbroich, Mario Scherer
-
Publication number: 20220025451Abstract: A kit for use in assessing the status of nucleic acid degradation and/or the integrity of one or more nucleic acids in a sample by amplifying at least two overlapping regions within at least one locus and detecting the amount of the at least two amplification products. The kit includes a primer and at least two probes that bind under stringent conditions to a sequence that shares at least 80% sequence identity to a sequence selected from the group of sequences consisting of SEQ ID NO. 6 to SEQ ID NO. 47 over a stretch of 80 base pairs, or to a reverse complement thereof. One of the at least two probes binds to one of the at least two overlapping regions and the other of the at least two probes binds to a non-overlapping region.Type: ApplicationFiled: October 13, 2021Publication date: January 27, 2022Inventors: Miroslav VRANES, Ralf PEIST, Mario SCHERER, Stefan Otto CORNELIUS
-
OLIGONUCLEOTIDE PRIMERS FOR QUANTIFYING AND/OR DETECTING HUMAN MALE DNA AND KITS CONTAINING THE SAME
Publication number: 20210395801Abstract: Oligonucleotide primers and probes for quantifying and/or detecting human male DNA in a forensic sample. The oligonucleotides are useful for amplifying a multicopy locus within the human Y-chromosome (MCL-Y) that shares at least 80% sequence identity to a sequence according to SEQ ID NO. 3 over a stretch of at least 60 base pairs. The oligonucleotides hybridize under stringent conditions to a nucleic acid having at least one sequence selected from the group consisting of SEQ ID NO. 3 to SEQ ID NO. 11 and/or SEQ ID NO. 17 to SEQ ID NO. 25. Kits including the oligonucleotide primers, probes and/or primer pairs and reagents for performing an amplification reaction on DNA recovered from a forensic sample are also disclosed.Type: ApplicationFiled: July 29, 2021Publication date: December 23, 2021Inventors: Miroslav VRANES, Ralf PEIST, Mario SCHERER, Stefan Otto CORNELIUS, Margaretha KÖNIG -
Patent number: 11149304Abstract: The present invention relates to a method for assessing the status of nucleic acid degradation and/or integrity of one or more nucleic acids in a sample, comprising the steps amplifying at least two overlapping regions within at least one locus (e.g. by heminested or nested PCR), and detecting the amount of the at least two amplification products through the use of at least two probes, wherein one probe binds to the region of overlap and the at least one other probe binds to a non-overlapping region. The invention further relates to a method of designing primers and/or probes for amplifying at least two overlapping regions within at least one locus, wherein the locus that is amplified is a single copy locus (SCL) or multicopy locus (MLC). The invention also relates to a primer and a primer pair for amplifying at least two overlapping regions from one nucleic acid template which is a multicopy locus present in 21 loci in the human genome. These primers and probes may be in a kit.Type: GrantFiled: September 15, 2017Date of Patent: October 19, 2021Assignee: Qiagen GmbHInventors: Miroslav Vranes, Ralf Peist, Mario Scherer, Stefan Otto Cornelius
-
Patent number: 11078527Abstract: According to a first aspect of the present invention, a method is provided for detecting and/or quantifying male genomic DNA in a sample, wherein the method comprises the step of amplification of a multicopy locus within the human Y-chromosome (MCL-Y), wherein said locus shares at least 80% sequence identity to a sequence according to SEQ ID NO. 3 over a stretch of at least 60 base pairs (bp). A second aspect of the present invention relates to a primer or primer pair which hybridizes under stringent conditions to a sequence according to SEQ ID NO. 3 and/or any of 4 to 11. The invention also relates to a kit.Type: GrantFiled: September 15, 2017Date of Patent: August 3, 2021Assignee: Qiagen GmbHInventors: Miroslav Vranes, Ralf Peist, Mario Scherer, Stefan Otto Cornelius, Margaretha König
-
Publication number: 20200087720Abstract: PCR that allows the researchers to amplify a desired DNA requiring only tiny amounts of sample. Such amplification reactions are technically challenging and are often hampered by several practical issues such as the presence of PCR inhibitors, sample degradation and low quantities of said sample. The invention addresses these issues with a method for evaluating the amplification efficiency and/or the presence of inhibitors and/or degradation and/or performing a quantification of a nucleic acid in a real-time amplification reaction comprising: optionally amplifying in a reaction composition a first target nucleic acid using a first primer pair in a real-time amplification reaction, (i) amplifying in said reaction composition one or more second internal nucleic acid control templates (IC) with a length of between 50 and 2000 nucleotides, wherein the second nucleic acid has a sequence selected from the group of: i) SEQ ID NO.Type: ApplicationFiled: September 15, 2017Publication date: March 19, 2020Inventors: Miroslav VRANES, Ralf PEIST, Mario SCHERER, Stefan Otto CORNELIUS
-
Publication number: 20190264256Abstract: The present invention relates to a method for assessing the status of nucleic acid degradation and/or integrity of one or more nucleic acids in a sample, comprising the steps amplifying at least two overlapping regions within at least one locus (e.g. by heminested or nested PCR), and detecting the amount of the at least two amplification products through the use of at least two probes, wherein one probe binds to the region of overlap and the at least one other probe binds to a non-overlapping region. The invention further relates to a method of designing primers and/or probes for amplifying at least two overlapping regions within at least one locus, wherein the locus that is amplified is a single copy locus (SCL) or multicopy locus (MLC). The invention also relates to a primer and a primer pair for amplifying at least two overlapping regions from one nucleic acid template which is a multicopy locus present in 21 loci in the human genome. These primers and probes may be in a kit.Type: ApplicationFiled: September 15, 2017Publication date: August 29, 2019Inventors: Miroslav VRANES, Ralf PEIST, Mario SCHERER, Stefan Otto CORNELIUS
-
Publication number: 20190249233Abstract: According to a first aspect of the present invention, a method is provided for detecting and/or quantifying male genomic DNA in a sample, wherein the method comprises the step of amplification of a multicopy locus within the human Y-chromosome (MCL-Y), wherein said locus shares at least 80% sequence identity to a sequence according to SEQ ID NO. 3 over a stretch of at least 60 base pairs (bp). A second aspect of the present invention relates to a primer or primer pair which hybridizes under stringent conditions to a sequence according to SEQ ID NO. 3 and/or any of 4 to 11. The invention also relates to a kit.Type: ApplicationFiled: September 15, 2017Publication date: August 15, 2019Inventors: Miroslav VRANES, Ralf PEIST, Mario SCHERER, Stefan Otto CORNELIUS, Margaretha KÖNIG
-
Publication number: 20160317949Abstract: The present invention relates to a chromatographic device for isolating and purifying nucleic acids, preferably genomic DNA, by gel filtration chromatography, a method for isolating and purifying nucleic acids, preferably genomic DNA, using this device and a kit comprising this device.Type: ApplicationFiled: July 7, 2016Publication date: November 3, 2016Inventors: Roland FABIS, Markus MÜLLER, Jörg HUCKLENBROICH, Mario SCHERER
-
Patent number: 9163228Abstract: The present invention relates to a method for isolating and purifying nucleic acids, preferably comprising genomic DNA, from biological samples comprising the steps of lysing the sample using a lysis buffer comprising a source of anionic surfactant ions, optionally disintegrating the RNA present in the lysate, precipitating the surfactant ions from the lysate, and separating the nucleic acids from the precipitate and further contaminants by size-exclusion chromatography. The invention furthermore relates to a lysis buffer, a method of lysing cells and a kit for the isolation and purification of nucleic acids.Type: GrantFiled: April 8, 2011Date of Patent: October 20, 2015Assignee: QIAGEN GmbHInventors: Roland Fabis, Markus Müller, Jörg Hucklenbroich, Mario Scherer
-
Publication number: 20140356860Abstract: The present invention provides a method for isolating nucleic acids from a veterinary whole blood sample, said method comprising at least the following steps a) preparing a binding mixture comprising—the lysed sample—at least one chaotropic agent—at least one alcohol—at least one polyoxyethylene fatty alcohol ether; b) passing the binding mixture through a column comprising a nucleic acid binding solid phase thereby binding the nucleic acids to the nucleic acid binding solid phase; c) optionally washing the nucleic acids while being bound to the solid phase; d) optionally eluting the nucleic acids from the solid phase. It was found that the addition of the specific non-ionic detergent overcomes the problems of the prior art methods, wherein the column clogs what prevents the efficient nucleic acid isolation from this difficult sample.Type: ApplicationFiled: September 13, 2011Publication date: December 4, 2014Applicant: QIAGEN GMBHInventors: Denis Flügge, Lillian Krüger, Mario Scherer
-
Publication number: 20130030163Abstract: The present invention relates to a method for isolating and purifying nucleic acids, preferably comprising genomic DNA, from biological samples comprising the steps of lysing the sample using a lysis buffer comprising a source of anionic surfactant ions, optionally disintegrating the RNA present in the lysate, precipitating the surfactant ions from the lysate, and separating the nucleic acids from the precipitate and further contaminants by size-exclusion chromatography. The invention furthermore relates to a lysis buffer, a method of lysing cells and a kit for the isolation and purification of nucleic acids.Type: ApplicationFiled: April 8, 2011Publication date: January 31, 2013Applicant: QIAGEN GMBHInventors: Roland Fabis, Markus Müller, Jörg Hucklenbroich, Mario Scherer
-
Publication number: 20130030165Abstract: The present invention relates to a chromatographic device for isolating and purifying nucleic acids, preferably genomic DNA, by gel filtration chromatography, a method for isolating and purifying nucleic acids, preferably genomic DNA, using this device and a kit comprising this device.Type: ApplicationFiled: April 8, 2011Publication date: January 31, 2013Applicant: Qiagen GmbHInventors: Roland Fabis, Markus Müller, Jörg Hucklenbroich, Mario Scherer
-
Publication number: 20130023655Abstract: The present invention relates to a method for selectively precipitating anionic surfactant ions from a liquid sample comprising anionic surfactant ions and nucleic acids, as well as to a kit for the isolation and purification of nucleic acids.Type: ApplicationFiled: April 8, 2011Publication date: January 24, 2013Applicant: Qiagen GmbHInventors: Roland Fabis, Markus Müller, Jörg Hucklenbroich, Mario Scherer
-
Publication number: 20130023656Abstract: The present invention relates to a gentle method for isolating and purifying nucleic acids from a biological cell comprising sample comprising at least DNA, RNA, and proteins, comprising at least the steps of 1. mixing the sample with a lysis buffer, 2. incubating the sample at a temperature within a range between 45° C. and 59° C. to obtain DNA as well as RNA or within a range between 60° C. and 70° C., to obtain DNA essentially free of RNA and 3. separating the nucleic acids from any contaminants.Type: ApplicationFiled: April 8, 2011Publication date: January 24, 2013Applicant: Qiagen GmbHInventors: Jörg Hucklenbroich, Mario Scherer